Published

The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)
Date: 2026-05-22
Source: OpenAlex
DOI: Unavailable
PubMed: Unavailable

Authors

Rachel N Clark

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Addiction Pharmacology Receptor Pharmacology Aging Clinical Trial Review Article Safety Toxicity Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07 Psilocybin and human longevitynpj Aging · 2026-04-03 Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal CortexEuropean Journal of Neuroscience · 2026-06-01 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12 Psilocybin treatment extends cellular lifespan and improves survival of aged mice.npj aging · 2025-07-08 Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01 An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17